APA

Cohan S. L., Moses H., Calkwood J., Tornatore C., LaGanke C., Smoot K. E., Meka V., Okwuokenye M., Hotermans C., Mendoza J. P., Mann M. K. & Meltzer L. A. (20181011). Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY). : Multiple sclerosis and related disorders.

Chicago

Cohan Stanley L, Moses Harold, Calkwood Jonathan, Tornatore Carlo, LaGanke Chris, Smoot Kyle E, Meka Venkata, Okwuokenye Macaulay, Hotermans Christophe, Mendoza Jason P, Mann Monica K and Meltzer Leslie A. 20181011. Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY). : Multiple sclerosis and related disorders.

Harvard

Cohan S. L., Moses H., Calkwood J., Tornatore C., LaGanke C., Smoot K. E., Meka V., Okwuokenye M., Hotermans C., Mendoza J. P., Mann M. K. and Meltzer L. A. (20181011). Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY). : Multiple sclerosis and related disorders.

MLA

Cohan Stanley L, Moses Harold, Calkwood Jonathan, Tornatore Carlo, LaGanke Chris, Smoot Kyle E, Meka Venkata, Okwuokenye Macaulay, Hotermans Christophe, Mendoza Jason P, Mann Monica K and Meltzer Leslie A. Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY). : Multiple sclerosis and related disorders. 20181011.